123 related articles for article (PubMed ID: 22200551)
1. Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation.
Agostini J; Benoist S; Seman M; Julié C; Imbeaud S; Letourneur F; Cagnard N; Rougier P; Brouquet A; Zucman-Rossi J; Laurent-Puig P
J Hepatol; 2012 Apr; 56(4):869-76. PubMed ID: 22200551
[TBL] [Abstract][Full Text] [Related]
2. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
[TBL] [Abstract][Full Text] [Related]
3. Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases.
van der Pool AE; Marsman HA; Verheij J; Ten Kate FJ; Eggermont AM; Ijzermans JN; Verhoef C
J Surg Oncol; 2012 Dec; 106(7):892-7. PubMed ID: 22552819
[TBL] [Abstract][Full Text] [Related]
4. Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
Jarzabek MA; Proctor WR; Vogt J; Desai R; Dicker P; Cain G; Raja R; Brodbeck J; Stevens D; van der Stok EP; Martens JWM; Verhoef C; Hegde PS; Byrne AT; Tarrant JM
PLoS One; 2018; 13(6):e0198099. PubMed ID: 29879147
[TBL] [Abstract][Full Text] [Related]
5. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.
Kandutsch S; Klinger M; Hacker S; Wrba F; Gruenberger B; Gruenberger T
Eur J Surg Oncol; 2008 Nov; 34(11):1231-6. PubMed ID: 18272318
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.
Nishigori N; Matsumoto M; Koyama F; Hayakawa M; Hatakeyayama K; Ko S; Fujimura Y; Nakajima Y
PLoS One; 2015; 10(11):e0143136. PubMed ID: 26580395
[TBL] [Abstract][Full Text] [Related]
7. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization.
Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Rather M; Rosso E; Addeo P; Jaeck D; Bachellier P
Ann Surg Oncol; 2012 Jul; 19(7):2230-7. PubMed ID: 22402811
[TBL] [Abstract][Full Text] [Related]
8. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.
Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A
Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348
[TBL] [Abstract][Full Text] [Related]
9. Histological features and severity of oxaliplatin-induced liver injury and clinical associations.
Nalbantoglu IL; Tan BR; Linehan DC; Gao F; Brunt EM
J Dig Dis; 2014 Oct; 15(10):553-60. PubMed ID: 25060628
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.
Brouquet A; Benoist S; Julie C; Penna C; Beauchet A; Rougier P; Nordlinger B
Surgery; 2009 Apr; 145(4):362-71. PubMed ID: 19303984
[TBL] [Abstract][Full Text] [Related]
11. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
Rubbia-Brandt L; Audard V; Sartoretti P; Roth AD; Brezault C; Le Charpentier M; Dousset B; Morel P; Soubrane O; Chaussade S; Mentha G; Terris B
Ann Oncol; 2004 Mar; 15(3):460-6. PubMed ID: 14998849
[TBL] [Abstract][Full Text] [Related]
12. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.
Nakano H; Oussoultzoglou E; Rosso E; Casnedi S; Chenard-Neu MP; Dufour P; Bachellier P; Jaeck D
Ann Surg; 2008 Jan; 247(1):118-24. PubMed ID: 18156931
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging flowmetry demonstrates portal vein dilatation subsequent to oxaliplatin therapy in patients with colorectal liver metastasis.
Urdzik J; Bjerner T; Wanders A; Duraj F; Haglund U; Norén A
HPB (Oxford); 2013 Apr; 15(4):265-72. PubMed ID: 23458313
[TBL] [Abstract][Full Text] [Related]
14. [Predictive factors for histopathological liver injury in the patients who received preoperative systemic chemotherapy for colorectal liver metastases].
Kudo D; Tsutsumi S; Akasaka H; Jin H; Ohashi T; Muroya T; Hasebe T; Sakamoto Y; Ishido K; Koyama M; Toyoki Y; Murata A; Narumi S; Kijima H; Hakamada K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2025-7. PubMed ID: 20037312
[TBL] [Abstract][Full Text] [Related]
15. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
[TBL] [Abstract][Full Text] [Related]
16. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis.
Rubbia-Brandt L; Lauwers GY; Wang H; Majno PE; Tanabe K; Zhu AX; Brezault C; Soubrane O; Abdalla EK; Vauthey JN; Mentha G; Terris B
Histopathology; 2010 Mar; 56(4):430-9. PubMed ID: 20459550
[TBL] [Abstract][Full Text] [Related]
17. Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury.
Slade JH; Alattar ML; Fogelman DR; Overman MJ; Agarwal A; Maru DM; Coulson RL; Charnsangavej C; Vauthey JN; Wolff RA; Kopetz S
Clin Colorectal Cancer; 2009 Oct; 8(4):225-30. PubMed ID: 19822514
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.
Overman MJ; Maru DM; Charnsangavej C; Loyer EM; Wang H; Pathak P; Eng C; Hoff PM; Vauthey JN; Wolff RA; Kopetz S
J Clin Oncol; 2010 May; 28(15):2549-55. PubMed ID: 20406923
[TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]